DD132270A5 - Verfahren zur herstellung von depot-steroidestern - Google Patents
Verfahren zur herstellung von depot-steroidesternInfo
- Publication number
- DD132270A5 DD132270A5 DD7600196384A DD19638476A DD132270A5 DD 132270 A5 DD132270 A5 DD 132270A5 DD 7600196384 A DD7600196384 A DD 7600196384A DD 19638476 A DD19638476 A DD 19638476A DD 132270 A5 DD132270 A5 DD 132270A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- steroidesters
- depot
- preparing
- preparing depot
- depot steroidesters
- Prior art date
Links
- VIQCGTZFEYDQMR-UHFFFAOYSA-N fluphenazine decanoate Chemical compound C1CN(CCOC(=O)CCCCCCCCC)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 VIQCGTZFEYDQMR-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0048—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/005—3 membered carbocyclic rings in position 12
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/008—3 membered carbocyclic rings in position 15/16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2558076A DE2558076C2 (de) | 1975-12-19 | 1975-12-19 | Depot-Steroidester, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD132270A5 true DD132270A5 (de) | 1978-09-13 |
Family
ID=5965325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD7600196384A DD132270A5 (de) | 1975-12-19 | 1976-12-15 | Verfahren zur herstellung von depot-steroidestern |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US4119626A (pl) |
| JP (1) | JPS5278860A (pl) |
| AT (1) | AT357704B (pl) |
| AU (1) | AU507111B2 (pl) |
| BE (1) | BE849553A (pl) |
| BG (2) | BG30475A3 (pl) |
| CA (1) | CA1086305A (pl) |
| CH (1) | CH630097A5 (pl) |
| CS (1) | CS194788B2 (pl) |
| DD (1) | DD132270A5 (pl) |
| DE (1) | DE2558076C2 (pl) |
| DK (1) | DK146629C (pl) |
| EG (1) | EG12383A (pl) |
| ES (1) | ES454297A1 (pl) |
| FI (1) | FI57263C (pl) |
| FR (1) | FR2335231A1 (pl) |
| GB (1) | GB1554199A (pl) |
| GR (1) | GR62084B (pl) |
| HU (1) | HU179343B (pl) |
| IE (1) | IE44320B1 (pl) |
| IL (1) | IL50981A (pl) |
| IT (1) | IT1065783B (pl) |
| LU (1) | LU76398A1 (pl) |
| MX (1) | MX3798E (pl) |
| NL (1) | NL7614023A (pl) |
| NO (2) | NO145620C (pl) |
| NZ (1) | NZ182890A (pl) |
| PH (1) | PH13907A (pl) |
| PL (1) | PL105525B1 (pl) |
| PT (1) | PT65973B (pl) |
| RO (1) | RO75383A (pl) |
| SE (1) | SE428930B (pl) |
| SU (1) | SU648105A3 (pl) |
| YU (1) | YU293176A (pl) |
| ZA (1) | ZA767510B (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7613248A (nl) * | 1976-11-26 | 1978-05-30 | Akzo Nv | Werkwijze voor het bereiden van nieuwe steroid- esters. |
| DE2848423A1 (de) * | 1978-11-08 | 1980-05-29 | Merck Patent Gmbh | Hydrocortisonester, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung |
| US4507290A (en) * | 1981-04-07 | 1985-03-26 | World Health Organization | Esters of 17 α-ethynyl 19-nor-testosterone and 17 α-ethynyl-18-homo-19-nor-testosterone and pharmaceutical compositions containing the same |
| DE3133082A1 (de) * | 1981-08-18 | 1983-03-10 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue hydrocortison-derivate, ihre herstellung und verwendung |
| JPS59184200A (ja) * | 1983-03-31 | 1984-10-19 | Takeda Chem Ind Ltd | ステロイド化合物、その製造法及び薬剤 |
| DE3511588A1 (de) * | 1985-03-27 | 1986-10-02 | Schering AG, Berlin und Bergkamen, 1000 Berlin | Waessrige kristallsuspension von steroidglykoestern |
| JPH02139518U (pl) * | 1989-04-25 | 1990-11-21 | ||
| DE4232521A1 (de) * | 1992-09-22 | 1994-03-24 | Schering Ag | Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB660199A (en) * | 1947-09-13 | 1951-10-31 | Sterling Drug Inc | Acyloxyalkanoates of hydroxylated hormones |
| GB817735A (en) * | 1955-08-26 | 1959-08-06 | Lab Francais Chimiotherapie | Improvements in or relating to steroidal compounds |
| US3082222A (en) * | 1958-03-26 | 1963-03-19 | Ott Erwin | Steroid acid-esters and salts thereof, and method of making the same |
| FR1326329A (fr) * | 1959-10-28 | 1963-05-10 | Préparation de sels d'hormones solubles dans l'eau et dans les lipides | |
| US3629245A (en) * | 1965-05-14 | 1971-12-21 | Roussel Uclaf | 16 17-isoxazolino-delta-1 3 5(10)-gonatrienes |
| US3856956A (en) * | 1967-02-02 | 1974-12-24 | Boots Pure Drug Co Ltd | 17-acyloxysteroids and their manufacture |
| GB1253828A (en) * | 1967-10-25 | 1971-11-17 | Shionogi & Co | 2,3-EPITHIO-5alpha-ANDROST-6-ENE STEROIDS |
| US3916002A (en) * | 1973-12-17 | 1975-10-28 | Taubert Hans Dieter | Oligomeric steroid esters, process for their production, and therapeutic compositions containing the same |
-
1975
- 1975-12-19 DE DE2558076A patent/DE2558076C2/de not_active Expired
-
1976
- 1976-11-19 RO RO7688502A patent/RO75383A/ro unknown
- 1976-11-24 IL IL50981A patent/IL50981A/xx unknown
- 1976-12-02 YU YU02931/76A patent/YU293176A/xx unknown
- 1976-12-03 MX MX765187U patent/MX3798E/es unknown
- 1976-12-08 US US748411A patent/US4119626A/en not_active Expired - Lifetime
- 1976-12-09 FI FI763544A patent/FI57263C/fi not_active IP Right Cessation
- 1976-12-15 NZ NZ182890A patent/NZ182890A/xx unknown
- 1976-12-15 PT PT65973A patent/PT65973B/pt unknown
- 1976-12-15 CH CH1578876A patent/CH630097A5/de not_active IP Right Cessation
- 1976-12-15 DD DD7600196384A patent/DD132270A5/xx unknown
- 1976-12-15 BG BG034917A patent/BG30475A3/xx unknown
- 1976-12-15 IE IE2738/76A patent/IE44320B1/en unknown
- 1976-12-15 BG BG049551A patent/BG31504A3/xx unknown
- 1976-12-15 SE SE7614107A patent/SE428930B/xx unknown
- 1976-12-16 LU LU76398A patent/LU76398A1/xx unknown
- 1976-12-16 ES ES454297A patent/ES454297A1/es not_active Expired
- 1976-12-16 DK DK566076A patent/DK146629C/da not_active IP Right Cessation
- 1976-12-17 ZA ZA767510A patent/ZA767510B/xx unknown
- 1976-12-17 NL NL7614023A patent/NL7614023A/xx not_active Application Discontinuation
- 1976-12-17 AT AT935576A patent/AT357704B/de not_active IP Right Cessation
- 1976-12-17 BE BE173395A patent/BE849553A/xx not_active IP Right Cessation
- 1976-12-17 GB GB52822/76A patent/GB1554199A/en not_active Expired
- 1976-12-17 PH PH19269A patent/PH13907A/en unknown
- 1976-12-17 SU SU762429452A patent/SU648105A3/ru active
- 1976-12-17 CA CA268,172A patent/CA1086305A/en not_active Expired
- 1976-12-17 PL PL1976194481A patent/PL105525B1/pl unknown
- 1976-12-17 NO NO764284A patent/NO145620C/no unknown
- 1976-12-17 HU HU76SCHE585A patent/HU179343B/hu unknown
- 1976-12-17 IT IT30524/76A patent/IT1065783B/it active
- 1976-12-17 CS CS768342A patent/CS194788B2/cs unknown
- 1976-12-18 EG EG773/76A patent/EG12383A/xx active
- 1976-12-20 FR FR7638306A patent/FR2335231A1/fr active Granted
- 1976-12-20 JP JP51154125A patent/JPS5278860A/ja active Granted
- 1976-12-20 AU AU20737/76A patent/AU507111B2/en not_active Expired
- 1976-12-28 GR GR52436A patent/GR62084B/el unknown
-
1980
- 1980-12-04 NO NO803670A patent/NO147717C/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD130857A5 (de) | Verfahren zur herstellung von n-phosphonomethylglycintriestern | |
| DD129103A5 (de) | Verfahren zur herstellung von n-phosphonomethylglycin | |
| DD128681A5 (de) | Verfahren zur herstellung von n hoch 2-arylsulfonyl-l-argininamiden | |
| DD129330A5 (de) | Verfahren zur herstellung von antitumorsubstanzen | |
| DD128782A5 (de) | Verfahren zur herstellung von n-alkyldiphenylaminen | |
| AT344147B (de) | Verfahren zur herstellung von acylcyaniden | |
| DD130036A5 (de) | Verfahren zur herstellung von optisch aktiven 11-desoxy-16-aryloxy-omega-tetranorprostaglandinen | |
| ATA691376A (de) | Verfahren zur herstellung von ueberzuegen | |
| DD129326A5 (de) | Verfahren zur herstellung von 1,4-diphenyl-3-pyrazolin-5-onen | |
| ATA314576A (de) | Verfahren zur herstellung von 4-nideralkyl-5- cyano-oxazolen | |
| DD132270A5 (de) | Verfahren zur herstellung von depot-steroidestern | |
| DD131556A5 (de) | Verfahren zur herstellung von 5-m-tolyoxyuracil | |
| AT348499B (de) | Verfahren zur herstellung von aethylchlorthioformiat | |
| AT349032B (de) | Verfahren zur herstellung von 4-alkyl-thiosemicarbaziden | |
| DD132435A5 (de) | Verfahren zur herstellung von indolochinolizinen | |
| DD131562A5 (de) | Verfahren zur herstellung von 5-pregnen-derivaten | |
| DD122961A5 (de) | Verfahren zur herstellung von diphenylaether-derivaten | |
| DD132431A5 (de) | Verfahren zur herstellung von aryloxy-1-amino-3-propanolen-2 | |
| AT350582B (de) | Verfahren zur herstellung von n-mehtyl-harn- stoffen | |
| AT352914B (de) | Verfahren zur herstellung von polyen- verbindungen | |
| DD131088A5 (de) | Verfahren zur herstellung von diaminoalkoxybenzolen | |
| AT376633B (de) | Verfahren zur herstellung von phosphornitriden | |
| DD128709A5 (de) | Verfahren zur herstellung von dekahydrochinolinderivaten | |
| DD128099A1 (de) | Verfahren zur herstellung von allantoin | |
| DD130416A4 (de) | Verfahren zur herstellung von o-nitrobenzylbromid |